Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

Medtronic has reported late-breaking data from the Evolut Low Risk Trial’s five-year outcomes of the Evolut TAVR system.

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...

Did you know men and women's heart cells prefer different kinds of fuel? Gender differences are emerging as scientists turn ...

Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing ...

GE HealthCare Technologies Inc. GEHC recently announced the U.S. launch of Flyrcado (flurpiridaz F 18) injection at the ongoing American College of Cardiology (ACC) Annual Scientific Session & Expo.

Wade’s CV impact, a digital stethoscope for HFrEF, and more. Every month, Section Editor L.A. McKeown curates a roundup of ...

DurAVR ® THV demonstrated a favorable hemodynamic profile sustained to one-year, with an Effective Orifice Area (EOA) of 2.1 + 0.2 cm 2, a Mean Pressure Gradient (MPG) of 8.6 + 2.6 mmHg and Doppler ...

A study led by bioengineers at the University of California San Diego sheds new light on how a type of heart valve disease, ...

Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

Smart radiator valves let you control the temperature in individual rooms when your central heating is on. They can be programmed and controlled remotely through your smartphone. Manufacturers promise ...

A groundbreaking heart procedure at MedStar Union Memorial Hospital has made Maryland history. Joan Mertz, 83, became the first patient in the state to undergo an artificial heart valve ...